Project Details
Description
A Phase 2, Randomized, Efficacy and Safety Study of Imprime PGG Injection in Combination with Cetuximab and Concomitant Paclitaxel and Carboplatin Therapy in Patients with Previously Untreated Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 10/27/09 → 10/31/12 |
Funding
- BIOTHERA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.